Belgian medical device firm Bedal raises €10.2M to expand its FlexGRIP catheter securement devices

Diepenbeek-based Bedal International, a Belgian medical device company specialising in next-gen catheter securement solutions, has closed a €10.2M funding round. The investment will support the company’s ongoing global growth.

The round was led by Belgian medtech VC fund White Fund, and SFPIM, the sovereign wealth fund of Belgium. US-based medtech investors, along with existing investors F3 Finance and LRM, also participated. The management team of Bedal contributed to the funding as well.

“White Fund and SFPIM are excited to support Bedal’s mission to improve patient care through its innovative devices,” says Eric Brandt of White Fund.

Céline Vaessen, CIO at SFPIM, adds, “We believe in Bedal’s potential to become the golden standard for catheter care. We are proud to be part of their promising growth journey and are committed to supporting their product development engine with the ambition of making a profound impact on the lives of patients and caregivers.”

Previously, Bedal also attracted an industry veteran, Steve Bierman, MD, who was the original creator of the industry and developed the catheter securement market. Dr. Bierman has taken on the role of co-CEO, bringing his extensive experience and vision to the company.

Solutions for securing catheters safely and easily

Bedal was founded based on the personal experiences of David D., one of the founders. During his cancer treatment, he faced practical challenges with intravenous catheters while hospitalised. This experience inspired him to improve the catheter experience for patients.

Bedal International, a scale-up in the medical device industry, focuses on specialised catheter securement solutions with its FlexGRIP products, prioritising patient well-being and healthcare provider convenience.

Bedal aims to enhance the overall quality of patient care by marketing FlexGRIP devices that secure various types of catheters (vascular, urinary, drainage), reducing complications and improving patient outcomes. 

FlexGRIP devices are used hospital-wide in cancer treatment, postoperative care, and intensive care units. Used in over 34 countries, the company has secured global deals with leading catheter companies.

Recently, Bedal also launched a pediatric range tailored to young patients’ needs.

Capital utilisation

The funding will support Bedal’s operational and commercial expansion, particularly in the US market.

Alexander Van Damme, CEO of Bedal International, says, “Since we founded Bedal, it has already been an incredible journey from launching the devices to growing into a global presence.”

“This new funding marks the beginning of a next chapter for us, focused on setting a new worldwide standard for catheter comfort and securement.”

Brief about the lead investors

White Fund is a Belgian VC fund dedicated to the medtech sector, providing high value-added investments. It supports companies through key development stages with a multidisciplinary team and extensive network, combining medtech expertise and investment experience.

The Federal Participation and Investment Company (SFPIM) is Belgium’s Sovereign Wealth Fund, providing ‘smart capital solutions’ to help Belgian SMEs and scale-ups become sector leaders. SFPIM contributes to the Belgian economy’s stability by anchoring strategic assets in both promising and established companies. It invests across various sectors, including life sciences, finance, aerospace, energy, transport, and impact investing.